Trial intelligence / Profile preview

Tongguan Capsule for MicroRNA Profiles in CHD Patients Undergoing PCI

NCT02850627Phase 4Unknown

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Jul 2016
Primary completion
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Tongguan Jiaonang in coronary heart disease (CHD), acute myocardial infarction (AMI), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Status: unknown.

02

Drugs

Tongguan Jiaonang
03

Conditions

coronary heart disease (CHD)acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT02850627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02850627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call